GlobeNewsWire
23 Jul 2026, 18:48 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
Insulet Corporation is facing a securities fraud class action lawsuit alleging it misled investors regarding defective manufacturing controls. — Legal challenges alleging systemic manufacturing failures and fraud create significant reputational risk and potential for large financial settlements.
-0.60Insulet issued two voluntary medical device corrections for Omnipod products due to manufacturing issues that could cause insulin under-delivery. — Product recalls and safety concerns regarding insulin delivery directly threaten the company's core product efficacy and regulatory standing.
-0.50Which stocks this story touches
The company is facing a securities fraud class action lawsuit following multiple voluntary medical device corrections and significant stock price drops.
Continue reading
6 related stories
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
34m ago
